Cargando…
_version_ 1785090882189393920
author Aletti, Federico Mario
Ruggeri, Annalisa
Angelillo, Piera
Mastaglio, Sara
Erbella, Federico
Palumbo, Diego
Calori, Giliola
Carrabba, Matteo G.
Querini, Patrizia Rovere
Ciceri, Fabio
Tresoldi, Cristina
Fragasso, Gabriele
Cobelli, Francesco De
Zampini, Matteo
Porta, Matteo Giovanni Della
Bernardi, Massimo
author_facet Aletti, Federico Mario
Ruggeri, Annalisa
Angelillo, Piera
Mastaglio, Sara
Erbella, Federico
Palumbo, Diego
Calori, Giliola
Carrabba, Matteo G.
Querini, Patrizia Rovere
Ciceri, Fabio
Tresoldi, Cristina
Fragasso, Gabriele
Cobelli, Francesco De
Zampini, Matteo
Porta, Matteo Giovanni Della
Bernardi, Massimo
author_sort Aletti, Federico Mario
collection PubMed
description
format Online
Article
Text
id pubmed-10430130
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104301302023-08-17 P1638: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IS A RISK FACTOR FOR PULMONARY VASCULAR THROMBOSIS IN PATIENTS WITH COVID-19. Aletti, Federico Mario Ruggeri, Annalisa Angelillo, Piera Mastaglio, Sara Erbella, Federico Palumbo, Diego Calori, Giliola Carrabba, Matteo G. Querini, Patrizia Rovere Ciceri, Fabio Tresoldi, Cristina Fragasso, Gabriele Cobelli, Francesco De Zampini, Matteo Porta, Matteo Giovanni Della Bernardi, Massimo Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430130/ http://dx.doi.org/10.1097/01.HS9.0000973424.73036.50 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Aletti, Federico Mario
Ruggeri, Annalisa
Angelillo, Piera
Mastaglio, Sara
Erbella, Federico
Palumbo, Diego
Calori, Giliola
Carrabba, Matteo G.
Querini, Patrizia Rovere
Ciceri, Fabio
Tresoldi, Cristina
Fragasso, Gabriele
Cobelli, Francesco De
Zampini, Matteo
Porta, Matteo Giovanni Della
Bernardi, Massimo
P1638: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IS A RISK FACTOR FOR PULMONARY VASCULAR THROMBOSIS IN PATIENTS WITH COVID-19.
title P1638: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IS A RISK FACTOR FOR PULMONARY VASCULAR THROMBOSIS IN PATIENTS WITH COVID-19.
title_full P1638: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IS A RISK FACTOR FOR PULMONARY VASCULAR THROMBOSIS IN PATIENTS WITH COVID-19.
title_fullStr P1638: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IS A RISK FACTOR FOR PULMONARY VASCULAR THROMBOSIS IN PATIENTS WITH COVID-19.
title_full_unstemmed P1638: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IS A RISK FACTOR FOR PULMONARY VASCULAR THROMBOSIS IN PATIENTS WITH COVID-19.
title_short P1638: CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IS A RISK FACTOR FOR PULMONARY VASCULAR THROMBOSIS IN PATIENTS WITH COVID-19.
title_sort p1638: clonal hematopoiesis of indeterminate potential (chip) is a risk factor for pulmonary vascular thrombosis in patients with covid-19.
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430130/
http://dx.doi.org/10.1097/01.HS9.0000973424.73036.50
work_keys_str_mv AT alettifedericomario p1638clonalhematopoiesisofindeterminatepotentialchipisariskfactorforpulmonaryvascularthrombosisinpatientswithcovid19
AT ruggeriannalisa p1638clonalhematopoiesisofindeterminatepotentialchipisariskfactorforpulmonaryvascularthrombosisinpatientswithcovid19
AT angelillopiera p1638clonalhematopoiesisofindeterminatepotentialchipisariskfactorforpulmonaryvascularthrombosisinpatientswithcovid19
AT mastagliosara p1638clonalhematopoiesisofindeterminatepotentialchipisariskfactorforpulmonaryvascularthrombosisinpatientswithcovid19
AT erbellafederico p1638clonalhematopoiesisofindeterminatepotentialchipisariskfactorforpulmonaryvascularthrombosisinpatientswithcovid19
AT palumbodiego p1638clonalhematopoiesisofindeterminatepotentialchipisariskfactorforpulmonaryvascularthrombosisinpatientswithcovid19
AT calorigiliola p1638clonalhematopoiesisofindeterminatepotentialchipisariskfactorforpulmonaryvascularthrombosisinpatientswithcovid19
AT carrabbamatteog p1638clonalhematopoiesisofindeterminatepotentialchipisariskfactorforpulmonaryvascularthrombosisinpatientswithcovid19
AT querinipatriziarovere p1638clonalhematopoiesisofindeterminatepotentialchipisariskfactorforpulmonaryvascularthrombosisinpatientswithcovid19
AT cicerifabio p1638clonalhematopoiesisofindeterminatepotentialchipisariskfactorforpulmonaryvascularthrombosisinpatientswithcovid19
AT tresoldicristina p1638clonalhematopoiesisofindeterminatepotentialchipisariskfactorforpulmonaryvascularthrombosisinpatientswithcovid19
AT fragassogabriele p1638clonalhematopoiesisofindeterminatepotentialchipisariskfactorforpulmonaryvascularthrombosisinpatientswithcovid19
AT cobellifrancescode p1638clonalhematopoiesisofindeterminatepotentialchipisariskfactorforpulmonaryvascularthrombosisinpatientswithcovid19
AT zampinimatteo p1638clonalhematopoiesisofindeterminatepotentialchipisariskfactorforpulmonaryvascularthrombosisinpatientswithcovid19
AT portamatteogiovannidella p1638clonalhematopoiesisofindeterminatepotentialchipisariskfactorforpulmonaryvascularthrombosisinpatientswithcovid19
AT bernardimassimo p1638clonalhematopoiesisofindeterminatepotentialchipisariskfactorforpulmonaryvascularthrombosisinpatientswithcovid19